Cardio-Vasculo-Renal Benefits of SGLT2 Inhibitors in Heart Failure: A Retrospective Study from a Lower-Resource Tertiary Center

<i>Background and Objectives:</i> Heart failure frequently coexists with CKD, compounding prognosis via cardio-renal interplay. Sodium glucose cotransporter 2 (SGLT2) inhibitors have demonstrated cardiovascular and renal benefits in randomized trials, but data remain limited in real-world lower-reso...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Olivia-Maria Bodea, Gabriel Florin Răzvan Mogoș, Nilima Rajpal Kundnani, Abhinav Sharma, Ovidiu Adam, Daniel Marius Duda-Seiman, Dana Velimirovici, Marioara Nicula-Neagu, Ovidiu Horea Bedreag, Simona Dragan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2026-01-01
Serie:	Medicina
Soggetti:	SGLT2i eGFR kidney function treatment algorithms glycemic control
Accesso online:	https://www.mdpi.com/1648-9144/62/2/256
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!